Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 4.86-11.939.9461.19-6.83

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 4.86 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19
Mar2020-6.83

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19
Positive
Mar2020 -6.83 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹20,743.6 Cr 20.9% 18.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

20.9%

18.2%

NA
SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses